In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid | Zendy

J S Knapp | Zendy; Arthur F. Back | Zendy; Anna Babst | Zendy; David N. Taylor | Zendy; R J Rice | Zendy

Open Access

In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid

Author(s) -

J S Knapp,

Arthur F. Back,

Anna Babst,

David N. Taylor,

R J Rice

Publication year - 1993

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.37.7.1552

Subject(s) - haemophilus ducreyi , cefixime , chancroid , microgram , microbiology and biotechnology , ciprofloxacin , trimethoprim , antibacterial agent , penicillin , tetracycline , ceftriaxone , antibiotics , biology , pasteurellaceae , haemophilus influenzae , in vitro , virology , human immunodeficiency virus (hiv) , syphilis , biochemistry

We determined the in vitro susceptibilities of 54 isolates of Haemophilus ducreyi from Thailand (29 isolates) and San Francisco (25 isolates) to penicillin G, tetracycline, amoxicillin-clavulanic acid, ceftriaxone, cefixime, erythromycin, azithromycin, ciprofloxacin, ofloxacin, and trimethoprim-sulfamethoxazole. Isolates were susceptible to or = 8.0 micrograms of tetracycline per ml, 11.1% of the isolates were resistant to and 40.9% of the isolates were resistant to trimethoprim-sulfamethoxazole (MIC, > or = 4/76 microgram/ml.)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research